Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Function of GATA3-PARP1 complex in breast cancer during GATA3-mediated cellular reprogramming

Award Number: F31GM146427
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 05/23/2023
PERIOD OF PERFORMANCE END DATE: 05/22/2025
AWARD TERMINATION DATE: 05/13/2025

Group Awards By:

View Award Description

Function of GATA3-PARP1 complex in breast cancer during GATA3-mediated cellular reprogramming - Project Summary GATA3 is a transcription factor that acts as a pioneer factor in breast cancer cells. However, the function of pioneer factors isn’t well understood. Specifically, how they activate silent chromatin is largely unknown. The long-term goal is to provide novel insights into the molecular mechanisms of pioneer factor- mediated cellular reprogramming at a chromatin level. More than 7 million GATA3 motifs exist in the human genome, but the experimental data from GATA3 ChIP- seq analysis indicates less than 1% of the motifs are occupied by the pioneer factor, GATA3. In addition to binding selectivity, pioneer factor action, including GATA3, is known to be site-specific (context-dependent), and they can only induce chromatin opening and enhancer formation at a subset of binding sites. The overall objective of this proposal is to identify the binding specificity of the pioneer factor, GATA3, in the genome and elucidate the impact of the interaction between GATA3 and chromatin-modification enzyme, Poly ADP-ribose polymerase 1 (PARP1), on gene activation. Our preliminary data strongly suggest that PARP1 is involved in such context-dependent action of GATA3. The central hypothesis is that GATA3-mediated cellular reprogramming is dependent on the PARP1 activity. The rationale for this study is that the identification of the roles of GATA3 and PARP1 interaction will provide novel molecular mechanisms underlying the site- specific expression of pioneer factor activities during cellular reprogramming. The central hypothesis will be tested by (1) investigating the function of PARP1 in the binding selectivity of GATA3 and (2) identifying the role(s) of GATA3-PARP1 interaction in gene activation. To test this hypothesis, I will use our unique DOX- inducible system in MDA-MB-231 basal breast cancer cells. In this system, exogenous GATA3 expression initiates mesenchymal-to-epithelial transition (MET). This system recapitulates GATA3 function in patient breast tumors since GATA3 expression is known to be higher in the luminal/epithelial breast tumors, and is essential for the maintenance of epithelial phenotypes. Under the first aim, we will investigate changes in GATA3 binding across the genome in the presence and absence of PARP1. The second aim will utilize next- generation sequencing to evaluate the effects that GATA3 and PARP1 have on the steps in pioneer factor- mediated cellular reprogramming. The proposed research is innovative because we are addressing the novel concept of context-dependent enhancer formation by a pioneer factor during cellular reprogramming. This research is significant because it will fill a critical gap in our knowledge about how pioneer factors mediate cell fate transition.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$26,920 )
2026	2024	UNIVERSITY OF NORTH DAKOTA	264 CENTENNIAL DR STOP 8371	GRAND FORKS	ND	58202	GRAND FORKS	USA	Biomedical Research and Research Training	000	2	3/24/2026	TERMINATION	-$26,920
														Subtotal = -$26,920

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	UNIVERSITY OF NORTH DAKOTA	264 CENTENNIAL DR STOP 8371	GRAND FORKS	ND	58202	GRAND FORKS	USA	Biomedical Research and Research Training	000	2	5/6/2025	TERMINATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $48,974 )
2024	2024	UNIVERSITY OF NORTH DAKOTA	264 CENTENNIAL DR STOP 8371	GRAND FORKS	ND	58202	GRAND FORKS	USA	Biomedical Research and Research Training	001	2	6/11/2024	NON-COMPETING CONTINUATION	$1,280
2024	2024	UNIVERSITY OF NORTH DAKOTA	264 CENTENNIAL DR STOP 8371	GRAND FORKS	ND	58202	GRAND FORKS	USA	Biomedical Research and Research Training	000	2	4/19/2024	NON-COMPETING CONTINUATION	$47,694
														Subtotal = $48,974

Issue Date FY: 2023 ( Subtotal = $47,694 )
2023	2023	UNIVERSITY OF NORTH DAKOTA	264 CENTENNIAL DR	GRAND FORKS	ND	58202	GRAND FORKS	USA	Biomedical Research and Research Training	001	1	5/23/2023	NEW	$0
2023	2023	UNIVERSITY OF NORTH DAKOTA	264 CENTENNIAL DR	GRAND FORKS	ND	58202	GRAND FORKS	USA	Biomedical Research and Research Training	000	1	5/23/2023	NEW	$47,694
2023	2023	UNIVERSITY OF NORTH DAKOTA	264 CENTENNIAL DR	GRAND FORKS	ND	58202	GRAND FORKS	USA	Biomedical Research and Research Training	002	1	5/23/2023	NEW	$0
														Subtotal = $47,694

Grand Total All Awards = $69,748

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Function of GATA3-PARP1 complex in breast cancer during GATA3-mediated cellular reprogramming

Award Number: F31GM146427

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 05/23/2023

PERIOD OF PERFORMANCE END DATE: 05/22/2025

AWARD TERMINATION DATE: 05/13/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer